Isracann Biosciences Pitch Deck slide image

Isracann Biosciences Pitch Deck

6 Israel's Regulatory Overview Israeli government granted export approvals in Q2, 2020 In 2007 Israel became the first country to allow medical research and cannabis cultivation. Now its the 3rd country in the world to allow exports. Cannabis is legal for medical purposes in Israel & decriminalized for recreational use. Patients purchase directly from pharmacies. Isracann's focus is on the acquisition of nursery, cultivation and manufacturing licenses. If successful, this strategy will allow Isracann to control the value chain and maximize value to its shareholders. Exports now legal with licenses being granted under trial basis 6 types of licenses Nursery Cultivation Manufacture Distribution Pharmacy Scientific research ישרא isracann BIOSCIENCES
View entire presentation